Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Liver TR-beta1 activation can alleviate nonalcoholic steatohepatitis

Oct. 13, 2021

Dapiglutide attenuates intestinal insufficiency in vivo

Oct. 8, 2021

Onegene Biotechnology presents OGB-21502, a novel antifibrotic agent

Oct. 6, 2021

French researchers patent BTNL8-binding antibodies for IBD

Oct. 4, 2021

Second Genome collaborates with VCU to generate biomarker for NASH with advanced fibrosis

Sep. 27, 2021

Sichuan Kelun-Biotech Biopharmaceutical presents new PPAR receptor agonists

Sep. 22, 2021

Kissei Pharmaceutical discovers EGLN1 inhibitors

Sep. 20, 2021

Preclinical evidence supports delivery of HNF4A mRNA NPs to attenuate liver fibrosis and cirrhosis

Sep. 16, 2021

Curadev Pharma presents new STING antagonists

Sep. 7, 2021

New DGAT-2 inhibitors discovered at Inorbit Therapeutics

Sep. 7, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...